Company intelligence / Profile preview
Wohlstand Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Wohlstand Pharma Private Limited focuses on research and development of pharmaceutical products, especially generics and complex generics, aiming at high safety and efficacy standards. The Chilean affiliate has advanced a proprietary antiviral candidate ("EMESY 3") into clinical studies targeting COVID‑19 and other viral infections. No published clinical results found as of now.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecules (generics and complex generics)
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Wohlstand Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wohlstand Pharmaceutical.